Research Innovation Acceleration

The Purdue Discovery to Innovation Accelerator, located in Discovery Park’s Bindley Bioscience Center, is tasked with launching life sciences discoveries down a commercialization path. In close cooperation with comprehensive technical and business partnerships at Purdue University and numerous industry and academic partners across the state of Indiana, our goal is to ensure that the inventors of cutting-edge technologies with biological/medical applications are supported as they advance from (A) proof of concept to (Z) product launch.   

Nationwide network 

Purdue’s accelerator is part of a unique network established in 2018 by the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response. Eight accelerators were funded initially. The Purdue Discovery to Innovation Accelerator is one of five that was added to the expanded network in 2019.

To build a pipeline of products for BARDA’s Division of Research, Innovation and Ventures, the Discovery to Innovation Accelerator will identify innovative products and solutions to meet biodefense and other health security needs. Accelerator staff will provide innovators with business and other expert services, such as regulatory support, and will introduce innovators to BARDA solicitations for funding consideration.

Areas of interest

Initially, the Purdue Discovery to Innovation Accelerator will address three areas of interest to BARDA’s Division of Research, Innovation and Ventures:

  • Early Notification to Act, Control, and Treat (ENACT), which funds technologies and platforms that provide early, actionable information to detect illnesses before people even know they are sick;
  • the Solving Sepsis initiative, which focuses on reducing the incidence, morbidity, mortality and cost of sepsis; and
  • other disruptive innovations, which seeks radically novel technologies that can transform health security.

More information

For more information, contact Michael Poderycki, team lead, at